Insider Transactions in Q4 2022 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
1,646
+0.22%
|
-
|
|
Dec 22
2022
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
482,767
-53.57%
|
-
|
|
Dec 22
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
9,465
+44.13%
|
-
|
|
Dec 14
2022
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.94%
|
$0
$0.35 P/Share
|
|
Dec 13
2022
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.5%
|
$250,000
$25.0 P/Share
|
|
Dec 13
2022
|
Tom Frohlich Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.1%
|
$0
$0.42 P/Share
|
|
Dec 01
2022
|
Eric Bjerkholt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,770
-14.94%
|
$126,940
$22.29 P/Share
|
|
Dec 01
2022
|
Eric Dobmeier President, CEO |
SELL
Open market or private sale
|
Direct |
30,000
-11.04%
|
$660,000
$22.31 P/Share
|
|
Dec 01
2022
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+18.09%
|
$0
$0.42 P/Share
|
|
Dec 01
2022
|
Eric Dobmeier President, CEO |
SELL
Bona fide gift
|
Direct |
25,000
-10.56%
|
-
|
|
Nov 30
2022
|
Eric Bjerkholt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,414
+29.83%
|
-
|
|
Nov 07
2022
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.5%
|
$220,000
$22.16 P/Share
|
|
Nov 07
2022
|
Tom Frohlich Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.1%
|
$0
$0.42 P/Share
|
|
Oct 06
2022
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,360
-4.87%
|
$139,840
$19.69 P/Share
|
|
Oct 06
2022
|
Tom Frohlich Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,582
+8.24%
|
-
|
|
Oct 06
2022
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,796
+11.51%
|
-
|
|
Oct 06
2022
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,557
-22.16%
|
$67,583
$19.69 P/Share
|
|
Oct 06
2022
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,152
+38.75%
|
-
|